Allergan gets US FDA approval for Zymaxid ophthalmic solution Allergan, Inc has received United States Food and Drug Administration (FDA) approval for Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms; Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group … Honeywell QuietClean Anti-Bacterial Air Purifier
Tech Pack includes:
* Wet & Dry Screen Cleaning x 4 * Lens Cleaning x 3 * Anti-Bacterial x 3…
Name (required)
Mail (will not be published) (required)
Website